Jump to content

Gut–brain axis

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Thinkpins (talk | contribs) at 05:25, 16 November 2021 (Added missing hyperlinks and citations.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Introduction

[1]

The gut-brain axis is a complex neural and biochemical information/signal network that facilitates communication between various parts of the central nervous system and enteric nervous system. To facilitate communication this bidirectional axis comprises various components of the immune system, endocrine system, nervous system and host microbiota interactions; whereby signals are transmitted from the brain to the gut and from the gut to the brain. Dysfunction of the gut-brain axis has been linked to numerous disorders of the nervous system and gastrointestinal(GI) tract[2]. These disorders are known to manifest in a variety of different ways, including emotional and/or cognitive disturbances including autism[3], anxiety[4] and depression[4] as well as GI problems[5][6], such as irritable bowel syndrome. Gut-microbiome interactions are thought to be a key component of many gut-brain axis related disorders and it’s thought that future therapeutic initiatives may be targeted at manipulating the gut-brain-microbiota axis.[2]

The primary components of the gut–brain axis are the central nervous system, endocrine system and immune system, including the hypothalamic–pituitary–adrenal axis (HPA axis), sympathetic and parasympathetic arms of the autonomic nervous system, the enteric nervous system, vagus nerve, and the gut microbiota.[7][8] One of the very first gut-brain interactions was demonstrated in the laboratory by Pavlov when he examined the cephalic phase of digestion and the release of gastric/pancreatic secretions in response to sensory signals, such as the smell and sight of food. [9][10] See Pavlov's Dog.

As of October 2016, gut flora's influence on the gut–brain axis were best understood through animal research and the various ways neural compounds, produced by gut flora, effected research subjects. Studies with humans – measuring variations in gut flora between people with various psychiatric and/or neurological conditions such as stress, or measuring effects of various probiotics (dubbed "psychobiotics" in this context) – had generally been small and were just beginning to be generalized.[11] Whether changes to gut flora are a result of disease, a cause of disease, or both in any number of possible feedback loops in the gut–brain axis, remained unclear.[12][7]

Since 2016, scientists understanding of the gut-brain axis has vastly improved and the most recent research has gone on to highlight the existence of a distinct microbiota-gut-axis and it's role in maintaining health and preventing disease.[13]

Enteric nervous system

Microbiota-gut-brain axis. [14]

The enteric nervous system(ENS) is one of the main divisions of the nervous system. The ENS consists of a mesh-like system of neurons that governs the function of the gastrointestinal system and thus it's often referred to as a "second brain". The ENS can operate autonomously. It normally communicates with the central nervous system (CNS) through the parasympathetic (e.g., via the vagus nerve) and sympathetic (e.g., via the prevertebral ganglia) nervous systems. However, vertebrate studies show that when the vagus nerve is severed, the enteric nervous system continues to function.[15]

In vertebrates, the enteric nervous system includes efferent neurons, afferent neurons, and interneurons, all of which make the enteric nervous system capable of carrying reflexes in the absence of CNS input. The sensory neurons report on mechanical and chemical conditions. Through intestinal muscles, the motor neurons control peristalsis and churning of intestinal contents. Other neurons control the secretion of enzymes. The enteric nervous system also makes use of more than 30 neurotransmitters, most of which are identical to the ones found in CNS, such as acetylcholine, dopamine, and serotonin. More than 90% of the body's serotonin lies in the gut, as well as about 50% of the body's dopamine; the dual function of these neurotransmitters is an active part of gut–brain research.[16][17][18]

The first of the gut–brain interactions was shown to be between the sight and smell of food and the release of gastric secretions, known as the cephalic phase, or cephalic response of digestion.[9][10]

Gut–brain integration

The hypothalamic-pituitary-adrenal (HPA) axis. [19]

The gut–brain axis is a bidirectional communication system that is important for maintaining homeostasis. Regulation is through the CNS and enteric nervous systems via neural, endocrine, immune, and metabolic pathways. A key component of the gut-brain axis communication network is the hypothalamic–pituitary–adrenal axis (HPA axis).[7] That term has been expanded to include the role of the gut flora as part of the "microbiome-gut-brain axis", a linkage of functions including the gut flora.[7][8][20]

Interest in the field was sparked by a 2004 study (Nobuyuki Sudo and Yoichi Chida) showing that germ-free mice (genetically homogeneous laboratory mice, birthed and raised in an antiseptic environment) showed an exaggerated HPA axis response to stress, compared to non-GF laboratory mice.[7]

The gut flora can produce a range of neuroactive molecules, such as acetylcholine, catecholamines, γ-aminobutyric acid, histamine, melatonin, and serotonin, which are essential for regulating peristalsis and sensation in the gut.[21] Changes in the composition of the gut flora due to diet, drugs, or disease correlate with changes in levels of circulating cytokines, some of which can affect brain function.[21] The gut flora also release molecules that can directly activate the vagus nerve, which transmits information about the state of the intestines to the brain.[21]

Likewise, chronic or acutely stressful situations activate the hypothalamic–pituitary–adrenal axis, causing changes in the gut flora and intestinal epithelium, and possibly having systemic effects.[21] Additionally, the cholinergic anti-inflammatory pathway, signaling through the vagus nerve, affects the gut epithelium and flora.[21] Hunger and satiety are integrated in the brain, and the presence or absence of food in the gut and types of food present also affect the composition and activity of gut flora.[21]

That said, most of the work that has been done on the role of gut flora in the gut–brain axis has been conducted in animals, including the highly artificial germ-free mice. As of 2016, studies with humans measuring changes to gut flora in response to stress, or measuring effects of various probiotics, have generally been small and cannot be generalized; whether changes to gut flora are a result of disease, a cause of disease, or both in any number of possible feedback loops in the gut–brain axis, remains unclear.[12]

The history of ideas about a relationship between the gut and the mind dates from the nineteenth century. The concepts of dyspepsia and neurasthenia gastrica referred to the influence of the gut on human emotions and thoughts.[22][23]

Proposed role of the gut–brain–skin axis in rosacea.[24]

Gut-brain-skin axis

A unifying theory that tied gastrointestinal mechanisms to anxiety, depression, and skin conditions such as acne was proposed as early as 1930.[25] In a paper in 1930, it was proposed that emotional states might alter normal intestinal flora which could lead to increased intestinal permeability and therefore contribute to systemic inflammation. Many aspects of this theory have been validated since then. Gut microbiota and oral probiotics have been found to influence systemic inflammation, oxidative stress, glycemic control, tissue lipid content, and mood.[26]

Research

Probiotics

A 2016 systematic review of laboratory animal studies and preliminary human clinical trials using commercially available strains of probiotic bacteria found that certain species of the Bifidobacterium and Lactobacillus genera (i.e., B. longum, B. breve, B. infantis, L. helveticus, L. rhamnosus, L. plantarum, and L. casei) had the most potential to be useful for certain central nervous system disorders.[27]

The gut epithelium is a multifunctional interface.[28]

Autism

Around 70% of people with autism also have gastrointestinal problems, and autism is often diagnosed at the time that the gut flora becomes established, indicating that there may be a connection between autism and gut flora.[29] Some studies have found differences in the gut flora of children with autism compared with children without autism – most notably elevations in the amount of Clostridium in the stools of children with autism compared with the stools of the children without[30] – but these results have not been consistently replicated.[29] Many of the environmental factors thought to be relevant to the development of autism would also affect the gut flora, leaving open the question of whether specific developments in the gut flora drive the development of autism or whether those developments happen concurrently.[8][29] As of 2016, studies with probiotics had only been conducted with animals; studies of other dietary changes to treat autism have been inconclusive.[12]

Parkinson's disease

As of 2015, one study had been conducted comparing the gut flora of people with Parkinson's disease to healthy controls; in that study people with Parkinson's had lower levels of Prevotellaceae and people with Parkinson's who had higher levels of Enterobacteriaceae had more clinically severe symptoms; the authors of the study drew no conclusions about whether gut flora changes were driving the disease or vice versa.[8]

Anxiety and mood disorders

As of 2018 work on the relationship between gut flora and anxiety disorders and mood disorders, as well as attempts to influence that relationship using probiotics or prebiotics (called "psychobiotics"), was at an early stage, with insufficient evidence to draw conclusions about a causal role for gut flora changes in these conditions, or about the efficacy of any probiotic or prebiotic treatment.[31][12]

People with anxiety and mood disorders tend to have gastrointestinal problems; small studies have been conducted to compare the gut flora of people with major depressive disorder and healthy people, but those studies have had contradictory results.[12]

Much interest was generated in the potential role of gut flora in anxiety disorders, and more generally in the role of gut flora in the gut–brain axis, by studies published in 2004 showing that germ-free mice have an exaggerated HPA axis response to stress caused by being restrained, which was reversed by colonizing their gut with a Bifidobacterium species.[20] Studies looking at maternal separation for rats shows neonatal stress leads to long-term changes in the gut microbiota such as its diversity and composition, which also led to stress and anxiety-like behavior.[32] Additionally, while much work had been done as of 2016 to characterize various neurotransmitters known to be involved in anxiety and mood disorders that gut flora can produce (for example, Escherichia, Bacillus, and Saccharomyces species can produce noradrenalin; Candida, Streptococcus, and Escherichia species can produce serotonin, etc.) the interrelationships and pathways by which the gut flora might affect anxiety in humans were unclear.[33]

In one study, germ-free mice underwent fecal transplants with microbes from humans with or without major depressive disorder (MDD). Mice with microbes from humans with MDD displayed more behaviors associated with anxiety and depression than mice transplanted with microbes from humans without MDD. The taxonomic composition of microbiota between depressed patients and healthy patients, as well as between the respective mice, also differed.[34] Germ-free mice in another study also displayed behaviors associated with anxiety and depression as compared to mice with normal microbiota, and had higher levels of corticosterone after exposure to behavioral tests.[35] Using rodents in microbiome and mental health studies allows researchers to compare behavior and microbial composition of rodents to humans, ideally to elucidate therapeutic application for mental disorders.

Additionally, there is a link between the gut microbiome, mood disorders and anxiety, and sleep. The microbial composition of the gut microbiome changes depending on the time of day, meaning that throughout the day, the gut is exposed to varying metabolites produced by the microbes active during that time. These time-dependent microbial changes are associated with differences in the transcription of circadian clock genes involved in circadian rhythm. One mouse study showed that altering clock gene transcription by disrupting circadian rhythm, such as through sleep deprivation, potentially has a direct effect on the composition of the gut microbiome.[36] Another study found that mice that could not produce the CLOCK protein, made by a clock gene, were more likely to develop depression.[36] Stress and sleep disturbances can lead to greater gut mucosal permeability via activation of the HPA axis. This in turn causes immune inflammatory responses that contribute to the development of illnesses that cause depression and anxiety.[36]

References

  1. ^ Suganya, Kanmani; Koo, Byung-Soo (2020-01). "Gut–Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and Immune Pathways to Improve Brain Functions". International Journal of Molecular Sciences. 21 (20): 7551. doi:10.3390/ijms21207551. {{cite journal}}: Check date values in: |date= (help)CS1 maint: unflagged free DOI (link)
  2. ^ a b Carabotti, Marilia; Scirocco, Annunziata; Maselli, Maria Antonietta; Severi, Carola (2015). "The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems". Annals of Gastroenterology : Quarterly Publication of the Hellenic Society of Gastroenterology. 28 (2): 203–209. ISSN 1108-7471. PMC 4367209. PMID 25830558.
  3. ^ Mayer, Emeran A.; Padua, David; Tillisch, Kirsten (2014-08-22). "Altered brain-gut axis in autism: Comorbidity or causative mechanisms?". BioEssays. 36 (10): 933–939. doi:10.1002/bies.201400075. ISSN 0265-9247.
  4. ^ a b Foster, Jane A.; McVey Neufeld, Karen-Anne (2013-05). "Gut–brain axis: how the microbiome influences anxiety and depression". Trends in Neurosciences. 36 (5): 305–312. doi:10.1016/j.tins.2013.01.005. ISSN 0166-2236. {{cite journal}}: Check date values in: |date= (help)
  5. ^ Koloski, N A; Jones, M; Kalantar, J; Weltman, M; Zaguirre, J; Talley, N J (2012-01-10). "The brain–gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study". Gut. 61 (9): 1284–1290. doi:10.1136/gutjnl-2011-300474. ISSN 0017-5749.
  6. ^ Berrill, J. W.; Gallacher, J.; Hood, K.; Green, J. T.; Matthews, S. B.; Campbell, A. K.; Smith, A. (2013-08-26). "An observational study of cognitive function in patients with irritable bowel syndrome and inflammatory bowel disease". Neurogastroenterology & Motility. 25 (11): 918–e704. doi:10.1111/nmo.12219. ISSN 1350-1925.
  7. ^ a b c d e Sudo, N; Chida, Y; Aiba, Y (2004). "Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice". J Physiol. 558 (1): 263–275. doi:10.1113/jphysiol.2004.063388. PMC 1664925. PMID 15133062. cited in: Wang, Y; Kasper, LH (May 2014). "The role of microbiome in central nervous system disorders". Brain Behav Immun. 38: 1–12. doi:10.1016/j.bbi.2013.12.015. PMC 4062078. PMID 24370461.
  8. ^ a b c d Dinan, T.G; Cryan, 2015 (2015). "The impact of gut microbiota on brain and behavior: implications for psychiatry". Curr Opin Clin Nutr Metab Care. 18 (6): 552–558. doi:10.1097/MCO.0000000000000221. PMID 26372511. S2CID 21424690. {{cite journal}}: |first2= has numeric name (help)
  9. ^ a b Filaretova, L; Bagaeva, T (2016). "The Realization of the Brain–Gut Interactions with Corticotropin-Releasing Factor and Glucocorticoids". Current Neuropharmacology. 14 (8): 876–881. doi:10.2174/1570159x14666160614094234. PMC 5333583. PMID 27306034.
  10. ^ a b Smeets, PA; Erkner, A; de Graaf, C (November 2010). "Cephalic phase responses and appetite". Nutrition Reviews. 68 (11): 643–55. doi:10.1111/j.1753-4887.2010.00334.x. PMID 20961295.
  11. ^ Wang, Huiying; Lee, In-Seon; Braun, Christoph; Enck, Paul (October 2016). "Effect of Probiotics on Central Nervous System Functions in Animals and Humans: A Systematic Review". J Neurogastroenterol Motil. 22 (4): 589–605. doi:10.5056/jnm16018. PMC 5056568. PMID 27413138.
  12. ^ a b c d e Schneiderhan, J; Master-Hunter, T; Locke, A (2016). "Targeting gut flora to treat and prevent disease". J Fam Pract. 65 (1): 34–8. PMID 26845162. Archived from the original on 2016-08-15. Retrieved 2016-06-25.
  13. ^ Cryan, John F.; O'Riordan, Kenneth J.; Cowan, Caitlin S. M.; Sandhu, Kiran V.; Bastiaanssen, Thomaz F. S.; Boehme, Marcus; Codagnone, Martin G.; Cussotto, Sofia; Fulling, Christine; Golubeva, Anna V.; Guzzetta, Katherine E. (2019-10-01). "The Microbiota-Gut-Brain Axis". Physiological Reviews. 99 (4): 1877–2013. doi:10.1152/physrev.00018.2018. ISSN 1522-1210. PMID 31460832.
  14. ^ Natale, Gianfranco; Ryskalin, Larisa; Morucci, Gabriele; Lazzeri, Gloria; Frati, Alessandro; Fornai, Francesco (2021-08). "The Baseline Structure of the Enteric Nervous System and Its Role in Parkinson's Disease". Life. 11 (8): 732. doi:10.3390/life11080732. {{cite journal}}: Check date values in: |date= (help)CS1 maint: unflagged free DOI (link)
  15. ^ Li, Ying; Owyang, Chung (September 2003). "Musings on the Wanderer: What's New in Our Understanding of Vago-Vagal Reflexes? V. Remodeling of vagus and enteric neural circuitry after vagal injury". American Journal of Physiology. Gastrointestinal and Liver Physiology. 285 (3): G461–9. doi:10.1152/ajpgi.00119.2003. PMID 12909562.
  16. ^ Pasricha, Pankaj Jay. "Stanford Hospital: Brain in the Gut – Your Health".
  17. ^ Martinucci, I; et al. (2015). "Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders". Pharmacogenomics. 16 (5): 523–39. doi:10.2217/pgs.15.12. PMID 25916523.
  18. ^ Smitka, K; et al. (2013). "The role of "mixed" orexigenic and anorexigenic signals and autoantibodies reacting with appetite-regulating neuropeptides and peptides of the adipose tissue-gutbrain axis: relevance to food intake and nutritional status in patients with anorexia nervosa and bulimia nervosa". Int J Endocrinol. 2013: 483145. doi:10.1155/2013/483145. PMC 3782835. PMID 24106499.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  19. ^ Kairys, Norah; Schwell, Ari (2021-07-18). "[Figure, The hypothalamic-pituitary-adrenal (HPA) axis. Contributed...]". www.ncbi.nlm.nih.gov. Retrieved 2021-11-16.
  20. ^ a b Mayer, EA; Knight, R; Mazmanian, SK; et al. (2014). "Gut microbes and the brain: paradigm shift in neuroscience". J Neurosci. 34 (46): 15490–15496. doi:10.1523/JNEUROSCI.3299-14.2014. PMC 4228144. PMID 25392516.
  21. ^ a b c d e f Petra, AI; et al. (May 2015). "Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation". Clin. Ther. 37 (5): 984–95. doi:10.1016/j.clinthera.2015.04.002. PMC 4458706. PMID 26046241.
  22. ^ Manon Mathias and Alison M. Moore (eds), Gut Feeling and Digestive Health in Nineteenth-Century Literature, History and Culture. New York: Palgrave, 2018. ISBN 9780230303454
  23. ^ Alison M. Moore, Manon Mathias and Jørgen Valeur, Microbial Ecology in Health and Disease, Volume 30 (1), Special issue on the Gut–Brain Axis in History and Culture, 2019
  24. ^ Woo, Yu Ri; Han, Yu Jin; Kim, Hei Sung; Cho, Sang Hyun; Lee, Jeong Deuk (2020-01). "Updates on the Risk of Neuropsychiatric and Gastrointestinal Comorbidities in Rosacea and Its Possible Relationship with the Gut–Brain–Skin Axis". International Journal of Molecular Sciences. 21 (22): 8427. doi:10.3390/ijms21228427. {{cite journal}}: Check date values in: |date= (help)CS1 maint: unflagged free DOI (link)
  25. ^ Stokes; Pillsbury (December 1930). "The effect on the skin of emotional and nervous states: Theoretical and practical consideration of a gastro-intestinal mechanism". Archives of Dermatology and Syphilology. 22 (6): 962–993. doi:10.1001/archderm.1930.01440180008002.
  26. ^ Bowe, W. P.; Logan, A. C. (2011). "Acne vulgaris, probiotics and the gut-brain-skin axis - back to the future?". Gut Pathogens. 3 (1): 1. doi:10.1186/1757-4749-3-1. PMC 3038963. PMID 21281494.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  27. ^ Wang H, Lee IS, Braun C, Enck P (July 2016). "Effect of probiotics on central nervous system functions in animals and humans - a systematic review". J. Neurogastroenterol. Motil. 22 (4): 589–605. doi:10.5056/jnm16018. PMC 5056568. PMID 27413138. We reviewed the effect of probiotics on the central nervous system in randomized controlled trials in animals and humans, and analyzed the possibility of translating animal models to human studies because few human studies have been conducted to date. According to the qualitative analyses of current studies, we can provisionally draw the conclusion that B. longum, B. breve, B. infantis, L. helveticus, L. rhamnosus, L. plantarum, and L. casei were most effective in improving CNS function, including psychiatric disease-associated functions (anxiety, depression, mood, stress response) and memory abilities.
  28. ^ Santos, Susanne Fonseca; de Oliveira, Hadassa Loth; Yamada, Elizabeth Sumi; Neves, Bianca Cruz; Pereira, Antonio (2019). "The Gut and Parkinson's Disease—A Bidirectional Pathway". Frontiers in Neurology. 10: 574. doi:10.3389/fneur.2019.00574. ISSN 1664-2295.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  29. ^ a b c Buie, T (May 2015). "Potential Etiologic Factors of Microbiome Disruption in Autism". Clin. Ther. 37 (5): 976–83. doi:10.1016/j.clinthera.2015.04.001. PMID 26046240.
  30. ^ Chen, X; D'Souza, R; Hong, ST (2013). "The role of gut microbiota in the gut–brain axis: current challenges and perspectives". Protein & Cell. 4 (6): 403–14. doi:10.1007/s13238-013-3017-x. PMC 4875553. PMID 23686721.
  31. ^ Sarkar, Amar; Lehto, Soili M.; Harty, Siobhán; Dinan, Timothy G.; Cryan, John F.; Burnet, Philip W.J. (2016). "Psychobiotics and the Manipulation of Bacteria–Gut–Brain Signals". Trends in Neurosciences. 39 (11): 763–781. doi:10.1016/j.tins.2016.09.002. ISSN 0166-2236. PMC 5102282. PMID 27793434.
  32. ^ Foster, J.A.; McVey Neufelt, K.A. (2013). "Gut–brain axis: how the microbiome influences anxiety and depression". Trends in Neurosciences. 36 (5): 305–312. doi:10.1016/j.tins.2013.01.005. PMID 23384445. S2CID 14841718.
  33. ^ Saxena, R.; Sharma, V.K (2016). "A Metagenomic Insight Into the Human Microbiome: Its Implications in Health and Disease". In D. Kumar; S. Antonarakis (eds.). Medical and Health Genomics. Elsevier Science. p. 117. doi:10.1016/B978-0-12-420196-5.00009-5. ISBN 978-0-12-799922-7.
  34. ^ Zheng, P; Zeng, B; Zhou, C; Liu, M; Fang, Z; Xu, X; Zeng, L; Chen, J; Fan, S (2016-04-12). "Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism". Molecular Psychiatry. 21 (6): 786–796. doi:10.1038/mp.2016.44. ISSN 1359-4184. PMID 27067014. S2CID 9636895.
  35. ^ Crumeyrolle-Arias, Michèle; Jaglin, Mathilde; Bruneau, Aurélia; Vancassel, Sylvie; Cardona, Ana; Daugé, Valérie; Naudon, Laurent; Rabot, Sylvie (April 2014). "Absence of the gut microbiota enhances anxiety-like behavior and neuroendocrine response to acute stress in rats". Psychoneuroendocrinology. 42: 207–217. doi:10.1016/j.psyneuen.2014.01.014. ISSN 0306-4530. PMID 24636517. S2CID 33589074.
  36. ^ a b c Li, Yuanyuan; Hao, Yanli; Fan, Fang; Zhang, Bin (2018-12-05). "The Role of Microbiome in Insomnia, Circadian Disturbance and Depression". Frontiers in Psychiatry. 9: 669. doi:10.3389/fpsyt.2018.00669. ISSN 1664-0640. PMC 6290721. PMID 30568608.{{cite journal}}: CS1 maint: unflagged free DOI (link)
Retrieved from "https://en.wikipedia.org/w/index.php?title=Gut–brain_axis&oldid=1055493723"